MedPath

湖北唯森制药有限公司

Ownership
-
Established
2002-09-28
Employees
-
Market Cap
-
Website
www.hbwspharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20253384
Approval Date
Feb 20, 2025
NMPA

Levocetirizine Dihydrochloride Oral Solution

Product Name
盐酸左西替利嗪口服溶液
Approval Number
国药准字H20244952
Approval Date
Sep 19, 2024
NMPA

Paracetamol Oral Solution

Product Name
对乙酰氨基酚口服溶液
Approval Number
国药准字H20094205
Approval Date
Sep 14, 2024
NMPA

Dexibuprofen Oral Suspension

Product Name
右旋布洛芬口服混悬液
Approval Number
国药准字H20090073
Approval Date
Nov 3, 2023
NMPA

Pantoprazole Sodium Enteric-coated Capsules

Product Name
泮托拉唑钠肠溶胶囊
Approval Number
国药准字H20090075
Approval Date
Nov 3, 2023
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H42022807
Approval Date
Sep 8, 2020
NMPA

Ampicillin Capsules

Product Name
氨苄西林胶囊
Approval Number
国药准字H42022761
Approval Date
Sep 8, 2020
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H42022808
Approval Date
Sep 8, 2020
NMPA

复方头孢克洛干混悬剂

Product Name
熙蒙
Approval Number
国药准字H20041880
Approval Date
Mar 31, 2020
NMPA

Compound Sulfamethoxazde Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H42021191
Approval Date
Sep 16, 2015
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.